'Acute myeloid leukemia: a comprehensive review and 2016 update'.

De Kouchkovsky I, Abdul-Hay M. · 2016

Read 'Acute myeloid leukemia: a comprehensive review and 2016 update'. by De Kouchkovsky I, Abdul-Hay M. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5030376.txt.

Description

I. De Kouchkovsky and M. Abdul-Hay review acute myeloid leukemia in the Blood Cancer Journal in 2016. This cancer of immature white blood cells is the most common acute leukemia in adults, with over 20,000 new cases a year in the United States alone. Gene faults stall blood cell growth at an early stage, and the stuck cells crowd out healthy blood.

The review sorts patients into favorable, middle, and adverse risk groups by their chromosome patterns, refined by single-gene faults such as FLT3-ITD, NPM1, and CEBPA. Standard care still rests on two drug families plus stem cell transplant for those who can take it, but older patients, who make up most cases, often cannot and fare poorly. New targeted drugs offer gentler, more precise attacks, though the disease's variety means no single drug will serve all. Better gene profiling, the authors argue, is the path to steady gains.

Catalog record

CREATORDe Kouchkovsky I, Abdul-Hay M.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5030376

Browse the full library · About the Tower of Babel